Literature DB >> 23094939

Accurate assessment of drooling severity with the 5-minute drooling quotient in children with developmental disabilities.

Karen van Hulst1, Robert Lindeboom, Jan van der Burg, Peter Jongerius.   

Abstract

AIM: The aims of this study were to examine whether objective measurements of the 10-minute drooling quotient (DQ10) and the 5-minute drooling quotient (DQ5) are interchangeable; to assess agreement between the measurements and their accuracy in classifying drooling severity; and to develop a time-efficient clinical assessment.
METHOD: The study cohort included 162 children (61 females, 101 males; mean age 11 y 6 mo, SD 4 y 5 mo, range 3 y 9 mo-22 y 1 mo) suffering from moderate to profuse drooling. One hundred and twenty-four had cerebral palsy and 38 had other developmental disabilities. Seventy-four of the participants were ambulant and 88 non-ambulant. The original DQ10 was recalculated into a 5-minute score (DQ5). Assessments were undertaken while the participants were in a rest situation (DQ(R)) and while they were active (DQ(A)). Agreement in scores was quantified using intraclass correlations and Bland-Altman plots. To classify drooling, area under the receiver operating characteristic curve analysis was used to compare accuracy of the DQ10 and DQ5 at rest and during activity.
RESULTS: Agreement between DQ10A, and DQ5(A), and between DQ10(R) and DQ5(R) was high (intraclass correlation coefficient >0.90). Moderate agreement existed between DQ(A) and DQ(R). DQ(A) scores were more accurate in classifying children's drooling behaviour. For DQ5(A), a cut-off point of 18 or more (drooling episodes/observation time) might indicate 'constant drooling'.
INTERPRETATION: The DQ10 and DQ5 can be used interchangeably. DQ(A) is most discriminative for drooling severity. For evaluating treatment efficiency the cut-off point can be used. For clinical and research purposes, the DQ5 is time efficient and cost saving while validity, and intrarater and interrater reliability are preserved. © The Authors. Developmental Medicine & Child Neurology
© 2012 Mac Keith Press.

Entities:  

Mesh:

Year:  2012        PMID: 23094939     DOI: 10.1111/j.1469-8749.2012.04428.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  8 in total

1.  Anticholinergic treatment for sialorrhea in children: A systematic review.

Authors:  Peng You; Julie Strychowsky; Karan Gandhi; Breanna A Chen
Journal:  Paediatr Child Health       Date:  2021-08-27       Impact factor: 2.600

2.  Impact and management of drooling in children with neurological disorders: an Italian Delphi consensus.

Authors:  Antonella Riva; Elisabetta Amadori; Maria Stella Vari; Alberto Spalice; Vincenzo Belcastro; Maurizio Viri; Donatella Capodiferro; Antonino Romeo; Alberto Verrotti; Pasquale Striano
Journal:  Ital J Pediatr       Date:  2022-07-19       Impact factor: 3.288

Review 3.  [Feeding, eating, and swallowing disorders in infants and children : An overview].

Authors:  C Schwemmle; C Arens
Journal:  HNO       Date:  2018-07       Impact factor: 1.284

4.  Changes in severity and impact of drooling after submandibular gland botulinum neurotoxin A injections in children with neurodevelopmental disabilities.

Authors:  Karen Van Hulst; Jan Jw Van Der Burg; Peter H Jongerius; Alexander Ch Geurts; Corrie E Erasmus
Journal:  Dev Med Child Neurol       Date:  2019-11-14       Impact factor: 5.449

5.  Cost-effectiveness of botulinum neurotoxin A versus surgery for drooling: a randomized clinical trial.

Authors:  Stijn Bekkers; Kim J van Ulsen; Eddy M M Adang; Arthur R T Scheffer; Frank J A van den Hoogen
Journal:  Dev Med Child Neurol       Date:  2020-07-24       Impact factor: 5.449

Review 6.  Drooling outcome measures in paediatric disability: a systematic review.

Authors:  E Sforza; R Onesimo; C Leoni; V Giorgio; F Proli; F Notaro; E M Kuczynska; A Cerchiari; A Selicorni; D Rigante; G Zampino
Journal:  Eur J Pediatr       Date:  2022-04-20       Impact factor: 3.860

7.  Can muscle vibration be the future in the treatment of cerebral palsy-related drooling? A feasibility study.

Authors:  Emanuele F Russo; Rocco S Calabrò; Patrizio Sale; Filomena Vergura; Maria C De Cola; Angela Militi; Placido Bramanti; Simona Portaro; Serena Filoni
Journal:  Int J Med Sci       Date:  2019-09-20       Impact factor: 3.738

8.  Botulinum Toxin Injections for Treatment of Drooling in Children with Cerebral Palsy: A Systematic Review and Meta-Analysis.

Authors:  Shang-An Hung; Chung-Lun Liao; Wei-Pin Lin; Jason C Hsu; Yao-Hong Guo; Yu-Ching Lin
Journal:  Children (Basel)       Date:  2021-11-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.